Scholarlink

Background <p>Cystic echinococcosis is a significant parasitic disease that predominantly affects the liver and lungs in humans. Its diagnosis relies mainly on imaging techniques such as ultrasound and computed tomography, supported byserological tests, including enzyme-linked immunosorbent assay and immunoblotting, which are commonly used inhuman serodiagnosis. Conventional serological assays frequently show variable sensitivity, particularly in pulmonary, inactive, or calcified cysts, and may yield false-negative or cross-reactive results.</p> Methods <p>Recent advances in recombinant antigen-based assays and nanobiosensors technologies have further improved diagnostic sensitivity and specificity. Current studies on recombinant antigens such as 2B2t, P29, and multiepitope constructs have markedly improved diagnostic performance compared with crude hydatid fluid preparations.</p> Results <p>The combination of these methods enhances diagnostic accuracy.</p> Conclusion <p>This review focuses explicitly on diagnostic approaches in humans, with emphasis on immunological, serological, and emerging biotechnological tools. Given the considerable variability in the performance of individual techniques, a combined, multidisciplinary diagnostic approach is essential for early and accurate detection, ultimately improving clinical management and patient outcomes. Integrating high-performance recombinant antigens with nanotechnology-enhanced detection systems may shape the next generation of CE diagnostics, particularly in endemic and low-resource regions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Recent advances in clinical and laboratory diagnosis of hydatid cyst: from imaging to recombinant and nanobiosensor-based approaches

  • 期刊论文

  • 发表日期：

    2026年3月18日

查看全文
  • Abolfazl Masoumi Koushk Mehdi,
  • Arshia Bozorgnia,
  • Amirsajjad Saffari,
  • Alireza Ghattan,
  • Amirhossein Jandaghian,
  • Amirali Jandaghian,
  • Mohammad Ghadirian,
  • Mohammad Reza Shiee,
  • Amin Moradi Hasan-Abad

摘要

Background

Cystic echinococcosis is a significant parasitic disease that predominantly affects the liver and lungs in humans. Its diagnosis relies mainly on imaging techniques such as ultrasound and computed tomography, supported byserological tests, including enzyme-linked immunosorbent assay and immunoblotting, which are commonly used inhuman serodiagnosis. Conventional serological assays frequently show variable sensitivity, particularly in pulmonary, inactive, or calcified cysts, and may yield false-negative or cross-reactive results.

Methods

Recent advances in recombinant antigen-based assays and nanobiosensors technologies have further improved diagnostic sensitivity and specificity. Current studies on recombinant antigens such as 2B2t, P29, and multiepitope constructs have markedly improved diagnostic performance compared with crude hydatid fluid preparations.

Results

The combination of these methods enhances diagnostic accuracy.

Conclusion

This review focuses explicitly on diagnostic approaches in humans, with emphasis on immunological, serological, and emerging biotechnological tools. Given the considerable variability in the performance of individual techniques, a combined, multidisciplinary diagnostic approach is essential for early and accurate detection, ultimately improving clinical management and patient outcomes. Integrating high-performance recombinant antigens with nanotechnology-enhanced detection systems may shape the next generation of CE diagnostics, particularly in endemic and low-resource regions.